Results 111 to 120 of about 39,529 (215)

Consumption pattern of enoxaparin in a non-teaching hospital (a cross-sectional prospective study)

Journal of Pharmacoeconomics and Pharmaceutical Management, 2022
Background: Drug use evaluation studies are conducted to assess the pattern of prescribing and administration of a drug. Deep vein thrombosis is one of the most important clinical issues around the world.
Mohammadreza Rafati, Shahram Ala, Mahsa Heydari, Bita Lashto-Aghaee   +3 more
doaj  

Neuromusculoskeletal ultrasound examination in Nicolau syndrome

PM&R, Volume 18, Issue 3, Page 347-349, March 2026.
Beytullah Yazar, Abdullah Emre Uğur, Mustafa Güngör Albayrak, Levent Özçakar   +3 more
wiley   +1 more source

Evaluating Anti-factor Xa Levels in Patients with Augmented Renal Clearance Receiving Enoxaparin Prophylaxis: An Exploratory Pilot Study

Journal of Research in Pharmacy Practice
Objective: Anticoagulation therapy, including enoxaparin, is crucial for preventing blood clots in patients at risk for thromboembolic events. However, due to enoxaparin’s enhanced renal elimination, proper prophylactic dosing may be challenging.
Zahra Sahraei, Azadeh Eshraghi, Saghar Barati   +2 more
doaj   +1 more source

A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease [PDF]

, 2005
Background It is well described that diabetes mellitus is a hypercoagulable state. It is also known that patients with renal dysfunction have impaired platelet aggregation and function.
Brophy, Donald F., Carr, Marcus E., Gehr, Todd W. B., Martin, Erika J.   +3 more
core   +1 more source

Enoxaparin pretreatment alleviates pentylenetetrazol–induced epileptic seizures in Wistar rats

Revista Científica
Epilepsy, is a prevalent neurological disorder characterized by recurring seizures. A low molecular weight heparin enoxaparin has multifaceted properties.
Huseyin Gungor, Nergiz Hacer Turgut
doaj   +1 more source

The PREVAIL trial and low-molecular-weight heparin for prevention of venous thromboembolism [PDF]

, 2008
Muir, K.W.
core   +1 more source

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure

Journal of Health Economics and Outcomes Research
# Background Chronic obstructive pulmonary disease (COPD) and heart failure (HF) are risk factors for venous thromboembolism (VTE). Enoxaparin and unfractionated heparin (UFH) help prevent hospital-associated VTE, but few studies have compared them in ...
Alpesh N. Amin, Alex Kartashov, Wilson Ngai, Kevin Steele, Ning Rosenthal   +4 more
doaj   +1 more source

Enoxaparin [PDF]

, 2020
openaire   +1 more source

Clinical Evaluation of Enoxaparin Prescription in Mazandaran Heart Center

Journal of Mazandaran University of Medical Sciences, 2020
Background and purpose: Drug utilization evaluation (DUE) is one of the most effective methods to assess the correct administration of drugs. Enoxaparin is one of the most commonly used anticoagulant which is widely used as prophylactic or curative ...
Gohar Eslami, Sogand Abedi, Shahaboddin Emami   +2 more
doaj  

Comparison of technetium-99m IgG with technetium-99m red blood cells labeling in cardiac blood-pool scintigraphy: A preliminary study [PDF]

, 2011
This first clinical prospective study was conducted to use of technetium-99m immunoglobulin G (99mTc-IgG) as compared with autologous 99mTc-red blood cells (RBC) in gated blood pool ventriculography.
Amini, A., Ansari, M., Asli, I.N., Assadi, M., Barekat, M., Jallalat, S., Javadi, H., Semnani, S.   +7 more
core